Effect of enflurane and fentanyl on the clinical characteristics of long-term succinylcholine infusion

[1]  R. Stoelting,et al.  Characteristics of Succinylcholine‐Produced Phase II Neuromuscular Block during Enflurane, Halothane, and Fentanyl Anesthesia , 1981, Anesthesia and analgesia.

[2]  R. Katz,et al.  Neuromuscular pharmacology. A clinical update and commentary. , 1980, British journal of anaesthesia.

[3]  H. H. Ali,et al.  Clinical Characteristics of Long‐Term Succinylcholine Neuromuscular Blockade during Balanced Anesthesia , 1980, Anesthesia and analgesia.

[4]  R. Katz,et al.  Magnitude, dose-requirement and mode of development of tachyphylaxis to suxamethonium in man. , 1978, British journal of anaesthesia.

[5]  C. Lee.  Train‐of‐Four Fade and Edrophonium Antagonism of Neuromuscular Block by Succinylcholine in Man , 1976, Anesthesia and analgesia.

[6]  C. Lee.  Dose relationships of phase II, tachyphylaxis and train-of-four fade in suxamethonium-induced dual neuromuscular block in man. , 1975, British journal of anaesthesia.

[7]  Ronald D. Miller,et al.  Neuromuscular Effects of Enflurane, Alone and Combined with d‐Tubocurarine, Pancuronium, and Succinylcholine, in Man , 1975, Anesthesiology.

[8]  J. A. Bain,et al.  Flow requirements for a modified mapleson D system during controlled ventilation , 1973, Canadian Anaesthetists' Society journal.

[9]  H. H. Ali,et al.  Stimulus frequency in the detection of neuromuscular block in humans. , 1970, British journal of anaesthesia.

[10]  C. Blitt,et al.  Depression of Twitch Response to Stimulation of the Ulnar Nerve during Ēthrane Anesthesia in Man , 1970, Anesthesiology.